Abrams Research Center on Neurogenomics
@arc_neuro
The ARC at Northwestern University is dedicated to advancing Alzheimer’s disease research with sophisticated genomics tools and AI analytics.
ID: 1832097914962743296
https://www.feinberg.northwestern.edu/sites/neurogenomics/ 06-09-2024 16:46:18
11 Tweet
60 Followers
881 Following
The team at Abrams Research Center on Neurogenomics, led by David Gate, is excited to explore their new lab! Using #ArtificialIntelligence, genetic research and global collaborations, they’re advancing Alzheimer’s disease research. #NMBetter
Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #Alzheimer’s disease patients Northwestern Feinberg School of Medicine nature.com/articles/s4159…
Excited to share our latest Nature Medicine study from our new center Abrams Research Center on Neurogenomics! 🧠✨ Using spatial transcriptomics & scRNA-seq, we uncover how Aβ-targeting immunotherapies shape microglial responses in AD patient brains. A thread with our key findings is below! 🧵(1/15)
This video describes the findings from our recent study conducted at Abrams Research Center on Neurogenomics. In the video, lead author Lynn van Olst and I discuss the findings and their implications for Alzheimer’s disease. youtu.be/pnRzktJRWAo
Alzheimer’s treatment may lie in the brain’s cleanup crew 🧠 For decades, scientists have worked to stop Alzheimer’s disease by removing amyloid beta plaques. Now, a Northwestern Medicine study finds the brain’s own immune cells can clear them more effectively.
In brains of people immunized against Aβ, postmortem omics reveal microglial plaque clearing pathways. Northwestern ow.ly/3cOl50VitbY
I am excited to present our new study out in Nature Medicine where we discover a novel synaptic protein biomarker to predict if and when someone will get Alzheimer’s disease dementia. Part 2/3 from my PhD work in the Tony Wyss-Coray lab. 🧵1/12 Full study 🔗: nature.com/articles/s4159…